IL-31 is a 24 kDa protein that forms a four-helix bundle structure, characteristic of the alpha-helical cytokine family. The recombinant form of IL-31 can be expressed in various systems, including E. coli and human embryonic kidney (HEK293) cells . The recombinant protein is often purified to a high degree of purity, typically greater than 95%, and is used in various research applications .
IL-31 plays a significant role in the immune system, particularly in the regulation of inflammatory responses. It is involved in the pathogenesis of several inflammatory disorders, including:
IL-31 exerts its effects by binding to a heterodimeric receptor complex composed of IL-31 receptor alpha (IL-31RA) and oncostatin M receptor (OSMR). This binding activates several downstream signaling pathways, including the JAK-STAT, PI3K-AKT, and MAPK pathways, leading to the production of various inflammatory mediators .
Recombinant human IL-31 is widely used in research to study its role in various diseases and to develop potential therapeutic interventions. It is used in cell culture experiments to investigate its effects on different cell types, such as epithelial cells and immune cells . Additionally, IL-31 is used in animal models to study its role in disease pathogenesis and to evaluate the efficacy of potential therapeutic agents .
Recombinant IL-31 is produced using various expression systems, including E. coli and HEK293 cells. The protein is typically purified using affinity chromatography and other purification techniques to achieve high purity levels. The purified protein is then lyophilized and stored under specific conditions to maintain its stability and bioactivity .
In conclusion, Interleukin-31 (Human Recombinant) is a crucial cytokine involved in various inflammatory processes. Its recombinant form is an essential tool in research, providing insights into its role in disease and aiding in the development of potential therapeutic interventions.